Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions

Abstract Gastro-esophageal adenocarcinomas (GEA) represent a severe global health burden and despite improvements in the multimodality treatment of these malignancies the prognosis of patients remains poor. HER2 overexpression/amplification has been the first predictive biomarker approved in clinica...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Francesca Battaglin, Madiha Naseem, Alberto Puccini, Heinz-Josef Lenz
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2018-07-01
Edice:	Cancer Cell International
Témata:	Gastro-esophageal cancer Molecular biomarkers HER-2 The Cancer Genome Atlas (TCGA) Asian Cancer Research Group (ACRG) Genomic profiling
On-line přístup:	http://link.springer.com/article/10.1186/s12935-018-0594-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!